⌑ The Labs HQ
Performance Lab·The Codex·Omega-3 (EPA/DHA)
⌑ Codex Protocol · Supplement · Essential

Omega-3 (EPA/DHA).

Eicosapentaenoic acid + Docosahexaenoic acid · marine-source long-chain n-3 fatty acids

Essential fatty acids the body cannot synthesize from precursors at meaningful rates. Tied to inflammation regulation, cardiovascular and cognitive function, and membrane integrity in every cell of the body.

⌑ Dose
2-4 g
EPA + DHA combined, daily
⌑ Form
Triglyceride
re-esterified TG > ethyl ester
⌑ Timing
With largest meal
fat-soluble, requires dietary fat
⌑ Test
Omega-3 Index
target 8% or higher

⌑ I · The MechanismHow it actually works.

Omega-3 fatty acids are a class of polyunsaturated fats with their first carbon-carbon double bond at the third position from the methyl (omega) end of the chain. Three forms are nutritionally relevant: alpha-linolenic acid (ALA, found in flax, chia, walnuts), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Only EPA and DHA — found primarily in marine sources — have direct biological activity in humans.[1]

The body can convert ALA to EPA and DHA, but the conversion rate is extremely low: approximately 5-10% for EPA and less than 1% for DHA in most adults. Conversion is further impaired by high omega-6 intake, age, and certain genetic variants. Functional sufficiency from plant sources is difficult to achieve without supplementation.[2]

EPA and DHA are incorporated into cell membranes throughout the body. They serve as substrates for specialized pro-resolving mediators (resolvins, protectins, maresins) that actively terminate inflammatory responses — a process distinct from the anti-inflammatory action of NSAIDs.[1] DHA is uniquely concentrated in the brain and retina, where it comprises approximately 30-40% of the fatty acids in gray matter and photoreceptor membranes.[3]

⌑ Mechanism Note

Most over-the-counter fish oil products contain 18% EPA and 12% DHA — about 300 mg of the active compounds per 1000 mg capsule. Reading the back of the bottle and counting the EPA + DHA milligrams (not the "fish oil" total) is the only way to know what you are actually taking.

⌑ II · The EvidenceWhat the research actually shows.

The omega-3 literature is vast. Key consolidated findings:

⌑ III · The ProtocolHow to actually use it.

⌑ Interactive Tool · "What you're actually taking"

Are you actually getting the dose?

Enter what's on YOUR bottle. The calculator strips out the marketing math and tells you the real EPA+DHA you're getting per day — and what you're paying per gram of active.

From supplement facts panel · in mg
From supplement facts panel · in mg
How many you actually take
What you paid for the bottle
Total capsules per bottle
Quick set ·
Actual Daily Dose
--
mg EPA + DHA
vs Target (2-4g)
--
of low target
Cost / Gram Active
--
USD per gram
Enter your bottle details above to see the breakdown.
Target range based on Calder 2017 [1] and Abdelhamid 2018 Cochrane [4]. Lower bound (2g) aligns with maintenance + general health; upper bound (4g) with REDUCE-IT-style cardiometabolic dosing.
⌑ Standard Protocol · Dose by Combined EPA + DHA

Dose

2-4 grams of combined EPA + DHA daily. Note: this is not the total "fish oil" on the front of the bottle. It is the sum of EPA + DHA listed on the supplement facts panel. A typical low-grade fish oil capsule provides ~300 mg combined — so reaching 2 g requires 6-7 capsules. Higher-concentrate formulations (60-80% EPA + DHA) are dramatically more efficient.

Timing

With your largest meal of the day. Fat-soluble, so absorption depends on dietary fat presence. Splitting the dose across two meals reduces gastrointestinal reflux ("fish burps") for those susceptible.

Duration

Indefinite for most. Erythrocyte membrane incorporation reaches steady state around 12 weeks; clinical effects on inflammation and triglycerides plateau around 8-12 weeks.[1]

Verification

The Omega-3 Index (OmegaQuant test, ~$50 USD) measures EPA + DHA as a percentage of total fatty acids in red blood cell membranes. Target: 8% or higher. Most Americans test between 3-5%. Retest 4 months after starting or changing dose.[9]

⌑ IV · Form and QualityThe fish oil market is a minefield.

Quality varies more in omega-3 supplements than in nearly any other category. Three considerations dominate:

1. Concentration

"1000 mg fish oil" tells you the capsule weight, not the active dose. The supplement facts panel lists EPA and DHA in milligrams. A 1000 mg low-grade product typically contains 180 mg EPA + 120 mg DHA = 300 mg active. A high-concentrate product might contain 500-700 mg active. The latter is more cost-effective and easier to dose.

2. Chemical form

Three forms exist: natural triglyceride (TG), re-esterified triglyceride (rTG), and ethyl ester (EE). Dyerberg et al. (2010) and subsequent studies found that triglyceride forms are absorbed approximately 50% better than ethyl ester forms. Most concentrated EE products are cheaper because they are technically easier to produce; rTG products cost more but deliver more.[10]

3. Oxidation / rancidity

Omega-3 oils are extremely susceptible to oxidative damage. Rancid fish oil is at best inactive and at worst pro-inflammatory. Quality manufacturers test peroxide value (PV) and totox (total oxidation) and publish certificates of analysis. Look for IFOS (International Fish Oil Standards) 5-star certification or equivalent third-party verification.[11]

⌑ Industry Note

Krill oil is marketed as superior because phospholipid-bound omega-3s are theoretically more bioavailable. Trial data on this advantage is inconsistent and the EPA + DHA content per dose is typically 1/3 to 1/2 of concentrated fish oil at higher cost. Algae-derived omega-3 is the strongest option for vegan formulations — equivalent bioavailability to marine sources.

⌑ V · Contraindications & ConsiderationsWhat to watch for.

⌑ VI · StackingWhat pairs well.

⌑ VII · ReferencesPrimary sources.

  1. Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. 2017;45(5):1105-1115. PMID: 28900017
  2. Burdge GC, Calder PC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction, Nutrition, Development. 2005;45(5):581-597. PMID: 16188209
  3. Bradbury J. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients. 2011;3(5):529-554. PMID: 22254110
  4. Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2018;11:CD003177. PMID: 30521670
  5. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). New England Journal of Medicine. 2019;380(1):11-22. PMID: 30415628
  6. Li K, Huang T, Zheng J, Wu K, Li D. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One. 2014;9(2):e88103. PMID: 24505395
  7. McGlory C, Calder PC, Nunes EA. The influence of omega-3 fatty acids on skeletal muscle protein turnover in health, disuse, and disease. Frontiers in Nutrition. 2019;6:144. PMID: 31555658
  8. Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry. 2019;9(1):190. PMID: 31383846
  9. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine. 2004;39(1):212-220. PMID: 15208005
  10. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2010;83(3):137-141. PMID: 20638827
  11. Albert BB, Cameron-Smith D, Hofman PL, Cutfield WS. Oxidation of marine omega-3 supplements and human health. BioMed Research International. 2013;2013:464921. PMID: 23691499
  12. Albert CM, Cook NR, Pester J, et al. Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial. JAMA. 2021;325(11):1061-1073. PMID: 33724323
← Back to the Codex